Literature DB >> 3717176

OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration.

R E Yodaiken, D Bennett.   

Abstract

Work-practice guidelines for personnel dealing with cytotoxic drugs (CDs) are presented. Current practices in the preparation, storage, administration, and disposal of CDs may expose pharmacists, nurses, physicians, and other health-care workers to high environmental levels of these drugs. OSHA has developed these guidelines to protect health-care workers from unnecessary exposure to CDs. A brief summary of the short-term and long-term hazards known to be associated with these drugs is presented. The risks to workers handling CDs are a combined result of the drugs' inherent toxicity and the extent to which workers are directly exposed to CDs via inhalation, absorption, and ingestion. Work-practice guidelines that can limit the exposure of workers to CDs and the equipment necessary to carry out these practices properly are described.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3717176

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  9 in total

Review 1.  The risks of handling cytotoxic drugs. II. Recommendations for working with cytotoxic drugs.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

2.  Factors Influencing Nurses' Use of Hazardous Drug Safe-Handling Precautions.

Authors:  Amy Callahan; Nancy J Ames; Mary Lou Manning; Kate Touchton-Leonard; Li Yang; Gwenyth Wallen
Journal:  Oncol Nurs Forum       Date:  2016-05-01       Impact factor: 2.172

3.  Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy?

Authors:  Sara Näslund Andréasson; Helena Anundi; Sig-Britt Thorén; Hans Ehrsson; Haile Mahteme
Journal:  J Oncol       Date:  2010-07-01       Impact factor: 4.375

4.  Building cancer nursing skills in a resource-constrained government hospital.

Authors:  R M Strother; Margaret Fitch; Peter Kamau; Kathy Beattie; Angela Boudreau; N Busakhalla; P J Loehrer
Journal:  Support Care Cancer       Date:  2012-05-08       Impact factor: 3.603

5.  Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery.

Authors:  Burak Turgut; Kenan Eren; Mehmet Mustafa Akın; Tamer Demir; Sabiha Kobat
Journal:  Drug Des Devel Ther       Date:  2014-05-02       Impact factor: 4.162

6.  Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study.

Authors:  Nicolas Simon; Michèle Vasseur; Marine Pinturaud; Marion Soichot; Camille Richeval; Luc Humbert; Michèle Lebecque; Ousseini Sidikou; Christine Barthelemy; Pascal Bonnabry; Delphine Allorge; Bertrand Décaudin; Pascal Odou
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

7.  Efficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces.

Authors:  Nicolas Simon; Nicolas Guichard; Pascal Odou; Bertrand Decaudin; Pascal Bonnabry; Sandrine Fleury-Souverain
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

8.  Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience.

Authors:  Ana Vaz da Conceição; Dora Bernardo; Lygia Vieira Lopes; Fernando Miguel; Fernanda Bessa; Fernando Monteiro; Cristina Santos; Blasques Oliveira; Lúcio Lara Santos
Journal:  Ecancermedicalscience       Date:  2015-10-01

Review 9.  Guidelines for safe handling of hazardous drugs: A systematic review.

Authors:  Mari A Bernabeu-Martínez; Mateo Ramos Merino; Juan M Santos Gago; Luis M Álvarez Sabucedo; Carmina Wanden-Berghe; Javier Sanz-Valero
Journal:  PLoS One       Date:  2018-05-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.